Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis have?
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis has 53 citations in the OpenAlex counts ScholarIQ stores.
When was Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis published?
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis has 2017 year in the ScholarIQ index.
What is the open-access status of Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis?
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis has closed oa status in the ScholarIQ index.
What is the DOI of Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis?
The DOI for Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis is on the source record.
What is the PMID of Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis?
The PMID for Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis is on the source record.
What is the OpenAlex record for Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis?
The OpenAlex for Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis is on the source record.